PP405 0.05% Topical Gel

DRUG2 trials

Sponsors

Pelage Pharmaceuticals, Inc.

Conditions

Androgenetic Alopecia

Phase 2

Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

CompletedNCT06393452

Pelage Pharmaceuticals, Inc.Androgenetic Alopecia

Start: 2024-06-05End: 2025-10-01Updated: 2025-12-11

Phase 2/3 Efficacy and Safety of PP405 in Adult Males

Not yet recruitingNCT07819435

Pelage Pharmaceuticals, Inc.Androgenetic Alopecia

Start: 2026-09-01End: 2028-06-01Target: 600Updated: 2026-09-18